CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-ß Signaling in Prostate Cancer.

Kardooni, Hoda; Gonzalez-Gualda, Estela; Stylianakis, Emmanouil; Saffaran, Sina; Waxman, Jonathan; Kypta, Robert M

Kardooni, Hoda; Gonzalez-Gualda, Estela; Stylianakis, Emmanouil; Saffaran, Sina; Waxman, Jonathan; Kypta, Robert M.

Afiliación

Kardooni H; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. h.kardooni@imperial.ac.uk.
Gonzalez-Gualda E; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. eg460@cam.ac.uk.
Stylianakis E; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. e.stylianakis17@imperial.ac.uk.
Saffaran S; School of Engineering, University of Warwick, Coventry CV4 7AL, UK. S.Saffaran.1@warwick.ac.uk.
Waxman J; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. j.waxman@imperial.ac.uk.
Kypta RM; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. r.kypta@imperial.ac.uk.

Cancers (Basel) ; 10(6)2018 May 28.

Article en En | MEDLINE | ID: mdl-29843383

Palabras clave

Dickkopf-3; PTGS2; TGF-ß signaling; gene promoter methylation; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google